These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33243113)

  • 1. The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants.
    Oz MD; Ozdemir F; Suzen HS
    Curr Drug Metab; 2021; 22(8):596-627. PubMed ID: 33243113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology.
    Mula M
    Curr Drug Metab; 2008 Oct; 9(8):730-7. PubMed ID: 18855610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenetics and antiepileptic drug metabolism: implication of genetic variants in cytochromes P450].
    Saldaña-Cruz AM; Sánchez-Corona J; Márquez de Santiago DA; García-Zapién AG; Flores-Martínez SE
    Rev Neurol; 2013 May; 56(9):471-9. PubMed ID: 23629749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant drug interactions between statins and antidepressants.
    Palleria C; Roberti R; Iannone LF; Tallarico M; Barbieri MA; Vero A; Manti A; De Sarro G; Spina E; Russo E
    J Clin Pharm Ther; 2020 Apr; 45(2):227-239. PubMed ID: 31587356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and drug-metabolizing enzymes--expert group report.
    Meyer UA; Amrein R; Balant LP; Bertilsson L; Eichelbaum M; Guentert TW; Henauer S; Jackson P; Laux G; Mikkelsen H; Peck C; Pollock BG; Priest R; Sjöqvist F; Delini-Stula A
    Acta Psychiatr Scand; 1996 Feb; 93(2):71-9. PubMed ID: 8686486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of CYP450 testing in the clinical setting.
    Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
    Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6.
    Vandel P
    World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes.
    Preskorn SH
    J Psychiatr Pract; 2020 Mar; 26(2):126-134. PubMed ID: 32134885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and forensic toxicology.
    Musshoff F; Stamer UM; Madea B
    Forensic Sci Int; 2010 Dec; 203(1-3):53-62. PubMed ID: 20828952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Interactions between Antiepileptic and Antidepressant Drugs.
    Mula M; Trimble MR
    World J Biol Psychiatry; 2003 Jan; 4(1):21-4. PubMed ID: 12582973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
    Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information.
    Boyce RD; Handler SM; Karp JF; Hanlon JT
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):139-50. PubMed ID: 22285509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs.
    Spina E; Perucca E
    Epilepsia; 2002; 43 Suppl 2():37-44. PubMed ID: 11903482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.
    Italiano D; Spina E; de Leon J
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1457-89. PubMed ID: 25196459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs.
    Ragia G; Dahl ML; Manolopoulos VG
    Curr Drug Metab; 2016; 17(3):227-36. PubMed ID: 26651976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles.
    Song MX; Rao BQ; Cheng BB; Wu Y; Zeng H; Luo YG; Deng XQ
    CNS Neurol Disord Drug Targets; 2017; 16(2):187-198. PubMed ID: 27549143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.
    Loiseau P
    Drug Saf; 1998 Dec; 19(6):495-510. PubMed ID: 9880092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.
    Vázquez M; Guevara N; Maldonado C; Guido PC; Schaiquevich P
    Biomed Res Int; 2020; 2020():3902740. PubMed ID: 32855964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.